VKSK.F Stock Overview
Engages in the wholesale and retail sale of pharmaceutical products in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Vital KSK Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥7.02 |
| 52 Week High | JP¥7.02 |
| 52 Week Low | JP¥6.20 |
| Beta | 0.089 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -28.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| VKSK.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | 0.3% |
| 1Y | n/a | 2.9% | 31.1% |
Return vs Industry: Insufficient data to determine how VKSK.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how VKSK.F performed against the US Market.
Price Volatility
| VKSK.F volatility | |
|---|---|
| VKSK.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: VKSK.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine VKSK.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 3,719 | Taisuke Murai | www.vitalksk.co.jp |
Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company is involved in the nursing care, agrochemical wholesale, and veterinary drug wholesale business. It also engages in the medical and pharmacy consulting business.
Vital KSK Holdings, Inc. Fundamentals Summary
| VKSK.F fundamental statistics | |
|---|---|
| Market cap | US$366.09m |
| Earnings (TTM) | US$39.01m |
| Revenue (TTM) | US$3.97b |
9.4x
P/E Ratio0.1x
P/S RatioIs VKSK.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VKSK.F income statement (TTM) | |
|---|---|
| Revenue | JP¥584.61b |
| Cost of Revenue | JP¥538.21b |
| Gross Profit | JP¥46.40b |
| Other Expenses | JP¥40.66b |
| Earnings | JP¥5.74b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 07, 2024
| Earnings per share (EPS) | 114.13 |
| Gross Margin | 7.94% |
| Net Profit Margin | 0.98% |
| Debt/Equity Ratio | 7.9% |
How did VKSK.F perform over the long term?
See historical performance and comparison